MeSH tree: D08.811.277.087
The American Society of Hematology (ASH) released guidelines on frontline management of acute lymphoblastic leukemia (ALL) in adolescents and young adults (AYAs), as well as the management of relapsed or refractory disease ...
13 hours ago
0
0
Colorectal cancer is one of the most common tumors among people over the age of 50. Although it is known to develop from small lesions or polyps, its exact causes are unknown—only a few risk factors are known—and it is ...
Oct 22, 2025
0
0
An international research team led by the University of Waterloo is developing technology to dissolve painful kidney stones in the urinary tract using tiny robots. The research is published in the journal Advanced Healthcare ...
Aug 12, 2025
0
36
The retina places a large energy demand on the body, in part due to the activity of photoreceptors.
Aug 4, 2025
0
0
University of Illinois Chicago scientists have redesigned a treatment for the most common pediatric leukemia to eliminate its severe side effects, like blood clots and liver damage. If approved, the new drug may be tolerated ...
Jan 31, 2025
0
43
A study conducted by researchers at the Kennedy Institute of Rheumatology has uncovered a pivotal role of asparagine metabolism in regulating B cell homeostasis and immune response.
Jan 3, 2025
0
101
A team of researchers from Carnegie Mellon University's Department of Biological Sciences and the University of Texas Southwestern Medical Center have uncovered how a subset of cells in the intestines change throughout the ...
Dec 17, 2024
0
1
A study led by Brazilian researchers and reported in an article published in the journal Nature Communications proposes that simultaneously targeting the enzyme glutaminase and the protein HuR, both of which are essential ...
Sep 27, 2024
0
25
Acute lymphoblastic leukemia (ALL) affects both children and adults, but children have better chances to be cured, with long-term survival rates of over 85% compared to 50%–75% in adults.
Aug 6, 2024
0
1
Despite having an overall survival rate of 94%, B-cell acute lymphoblastic leukemia (B-ALL), the most common childhood cancer, can prove challenging to treat, with survival among relapsed or resistant cases falling between ...
Apr 8, 2024
0
29
